Dongbang FTL wins for guggulsterol process patent

Published: 2004-09-23 06:56:00

Updated: 2004-09-23 06:56:00

Dongbang FTL said it has recently obtained a process patent for guggulsterol, which has been implicated for the treatment of disorders such as gastrointestinal disturbances, pancreatitis, gastric and pancreatic carcinomas, obesity, and cognition dysfunction.

The company noted that the patent r...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK